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Clonal selection and transcriptional reprogramming
(e.g., epithelial-mesenchymal transition or pheno-
type switching) are the predominant theories thought
to underlie tumor progression. However, a ‘‘division
of labor’’ leading to cooperation among tumor-cell
subpopulations could be an additional catalyst of
progression. Using a zebrafish-melanoma xenograft
model, we found that in a heterogeneous setting,
inherently invasive cells, which possess protease
activity and deposit extracellular matrix (ECM), co-
invade with subpopulations of poorly invasive cells,
a phenomenon we term ‘‘cooperative invasion’’.
Whereas the poorly invasive cells benefit from het-
erogeneity, the invasive cells switch from protease-
independent to an MT1-MMP-dependent mode of
invasion. We did not observe changes in expression
of the melanoma phenotype determinant MITF dur-
ing cooperative invasion, thus ruling out the neces-
sity for phenotype switching for invasion. Altogether,
our data suggest that cooperation can drive mela-
noma progression without the need for clonal selec-
tion or phenotype switching and can account for the
preservation of heterogeneity seen throughout tumor
progression.
INTRODUCTION
Tumors comprise subpopulations of transformed cells that are
genotypically or phenotypically divergent. In melanoma, cell
subpopulations have been characterized that differ in gene
expression profiles, proliferation rates, and invasiveness; lead-
ing to the definition of so-called proliferative and invasive phe-
notypes that correlate with relatively high and low expression,
respectively, of the melanocyte lineage determinant MITF
(Hoek et al., 2006, 2008). However, whether interactions be-
tween heterogeneous melanoma cell subpopulations contribute
to invasion and metastasis is unknown. To study the potential
significance of heterogeneity for the dissemination of melanoma688 Cell Reports 8, 688–695, August 7, 2014 ª2014 The Authorscells, we developed a xenograft model in zebrafish embryos
that allows monitoring of local invasion with high resolution.
To represent genotypes relevant to melanoma we selected
melanoma cell line pairs that harbor the V600E BRAF mutation,
the most common mutation present in melanoma (Wellbrock
and Hurlstone, 2010), but differ in their expression of MITF,
and as a consequence the individual cell lines are either
inherently invasive (MITFlow) or poorly invasive (MITFhigh). We
find that these divergent cell lines communicate reciprocally
and cooperate to invade collectively dependent on protease
activity and fibronectin deposition and without altering MITF
expression.RESULTS
Heterogeneity Confers Invasive Properties on
Individually Poorly Invasive Melanoma Cells
Invasive MITFlow WM266-4 cells or poorly invasive MITFhigh
501mel cells (Figure 1A; Arozarena et al., 2011; Ohanna et al.,
2011; Rozenberg et al., 2010) were injected into the pericardial
cavity of zebrafish embryos at 48 hr postfertilization (Figures
S1A and S1B available online). Both melanoma cell lines
(WM266-4-GFP and 501mel-mCherry) aggregated rapidly and
anchored to the body wall to form tumor-like masses (Figures
1B and S1C). As anticipated, WM266-4 cells invaded efficiently,
but 501mel cells displayed little invasion (Figure 1B). Strikingly,
however, in a heterogeneous situation, when WM266-4 and
501mel cells were present in equal ratios within the xenograft,
the invasion of 501mel cells increased markedly (Figure 1C). In
tissue sections of engrafted zebrafish embryos, infiltrating tumor
cells were found migrating away from the primary site through
solid tissue (Figure 1D). We enumerated the invading cells
located outside the pericardium (dashed line in Figure 1D). This
confirmed that the invasion of 501mel cells increased to levels
similar to WM266-4 cells (Figure 1E). This striking behavior was
also observed for another pair of MITFlow and MITFhigh mela-
noma cell lines—UACC62 and 888mel cells, respectively—(Fig-
ures S1D–S1F), suggesting this may be a general phenomenon.
Thus, melanoma cells that display divergent invasive pheno-
types in isolation interact symbiotically under heterogeneous cir-
cumstances, a phenomenon that we describe as ‘‘cooperative
invasion’’.
Figure 1. Heterogeneity Results in Coopera-
tive Invasion
(A) Western blot showing MITF expression in
WM266-4 and 501mel cells.
(B) Homogeneous xenografts imaged at 1 (upper)
and 4 days (lower) postinjection (dpi).
(C) Heterogeneous xenografts imaged at 1 (upper)
and 4 dpi (lower).
Arrows indicate directions of invasion; arrowhead
indicates autofluorescence.
(D) Section from engrafted embryo indicating pri-
mary tumor site (white dashed line) and infiltrating
melanoma cells (white arrows). Scale bars repre-
sent 100 mm.
(E) Quantitation of invasion depicted in (A) and (B);
mean ± SEM; Kruskal-Wallis test followed by
Dunn’s multiple comparisons test; **p < 0.01; nR
26 from three independent experiments.
See also Figure S1.Cooperative Invasion Requires the Activity of MT1-MMP
Further analysis revealed that WM266-4 cells were significantly
more likely to be the leading cell of an invasive file (Figure S2A).
Live imaging confirmed that over timeWM266-4 cells lead files of
invading cells (Figure S2B). Such behavior has been described
for tumor-associated fibroblasts, which contribute to the matrix
metalloproteinase (MMP)-mediated degradation of the extracel-
lularmembrane (ECM), thereby enabling epithelial cancer cells to
invade (Gaggioli et al., 2007). Real-time PCR revealed signifi-
cantly higher expression of the three most prominent cancer
related MMPs—MMP1, MMP2 and MT1-MMP—in WM266-4
cells compared to 501mel cells (Figure S2C), suggesting that
during cooperative invasion, WM266-4 cells could adopt a role
similar to fibroblasts.
We assessed the relevance of protease activity for coopera-
tive invasion by incubating engrafted embryos with a previously
described cocktail of protease inhibitors (Sahai and Marshall,
2003; Wolf et al., 2003). This had no effect on homogeneous
501mel xenografts, where no invasion occurred in any case
(Figures 2A and 2B). However, the invasion of 501mel cells in
heterogeneous xenografts was almost completely blocked in
the presence of the inhibitor mix (Figures 2A and 2B). This indi-
cates that the proteolytic cleavage of ECM is necessary for the
acquired invasion of 501mel cells. Homogeneous WM266-4
xenografts showed no difference in relative invasion whenCell Reports 8, 688–6treated with the protease inhibitors
compared to DMSO (Figures 2A and 2C),
suggesting that WM266-4 cells can use
a proteolytic-independent mechanism of
invasion, as has been described else-
where (Sahai and Marshall, 2003; Wolf
et al., 2003). Surprisingly, however, in het-
erogeneous xenografts treated with the
protease inhibitor mix WM266-4 cells
showed a dramatic decrease in invasion
(Figures 2A and 2C). Suppression of
cooperative invasion but not invasion of
homogeneous WM266-4 cells was alsoobserved when the pan-MMP inhibitor GM6001 was used alone,
albeit at higher concentration (Figures S2D and S2E). Because
MT1-MMP is a major regulator of protease-driven invasion
(Sabeh et al., 2004), we depleted MT1-MMP expression in
WM266-4 cells using RNAi; this efficiently suppressed coopera-
tive invasion, although again did not affect the invasion of homo-
geneous WM266-4 cells (Figures 2D–2F and S2F). Further
corroborating the importance of MT1-MMP for cooperative inva-
sion, invasive UACC62 cells also express significantly more
MT1-MMP than poorly invasive 888mel cells (Figure S1F).
Thus, we not only identify a crucial role for MT1-MMP in cooper-
ative invasion, but also demonstrate that it is tumor cell protease
activity rather than host protease activity that is required for
cooperative invasion.
The preceding experiments indicated that the presence of
501mel cells suppressed the protease-independent invasive
potential of WM266-4 cells. To further investigate the mecha-
nism of crosstalk, we cultured WM266-4 cells as spheroids
embedded in pepsin-extracted bovine collagen in the absence
or presence of 501mel cells and added protease inhibitors to
the culture system (Figure 3A). We found that under these condi-
tions, homogeneous WM266-4 cells invaded the matrix singly
with a predominantly rounded morphology (Figure 3B), in line
with previously published data (Arozarena et al., 2011; Sahai
and Marshall, 2003). However, exposure to soluble factors95, August 7, 2014 ª2014 The Authors 689
Figure 2. MMP Inhibition Suppresses Coop-
erative Invasion
(A) Homogeneous (upper) or heterogeneous (bot-
tom) xenografts were treated with either the
vehicle control DMSO (left) or protease inhibitor
cocktail (right). Scale bars represent 100 mm.
(B) Quantitation of 501mel invasion depicted in (A);
mean ± SEM; Kruskal-Wallis test followed by
Dunn’s multiple comparisons test; **p < 0.01;
nR 9 from three independent experiments.
(C) Quantitation of WM266-4 invasion depicted in
(A); mean ± SEM; Kruskal-Wallis test followed by
Dunn’s multiple comparisons test; *p < 0.05; n R
13 from three independent experiments.
(D) Western blot showing MT1-MMP expression in
WM266-4 transfected with either control or MT1-
MMP specific siRNA.
(E) Quantitation of invasion of WM266-4 cells in
homogeneous xenografts wherein WM266-4
cells have been transfected with either control or
MT1-MMP-specific siRNA; mean ± SEM; Mann-
Whitney test; n R 21 from three independent
experiments.
(F) Quantitation of invasion of WM266-4 and
501mel in heterogeneous xenografts wherein
WM266-4 cells have been transfected with either
control or MT1-MMP specific siRNA; mean ± SEM;
Kruskal-Wallis test followed by Dunn’s multiple
comparisons test; ****p < 0.0001; n R 24 from
three independent experiments.
See also Figure S2.derived from 501mel cells resulted in a reduction of invasion and
a switch to an elongated mode of invasion (Figure 3B), which is
known to be protease dependent.
Cooperative Invasion Involves Changes in the ECM
MMPs and fibronectin are coexpressed in melanoma cells (Ka-
moshida et al., 2013), supporting the idea that ECM deposition
and degradation are closely coordinated. Also, fibronectin is
associated with melanoma progression (Gaggioli et al., 2005)
and can regulate the organization of type I collagen fibrils (Sottile
and Hocking, 2002). To analyze the involvement of type I
collagen and fibronectin in cooperative invasion, we first per-
formed whole-mount immunofluorescence staining on homoge-
neous WM266-4 and 501mel xenografts: WM266-4 xenografts
were surrounded by abundant type I collagen and fibronectin,
but this was not detectable in 501mel xenografts (Figure 4A).
Western blotting revealed a strong expression of both ECM pro-
teins in WM266-4 cells, but barely detectable expression in
501mel cells (Figure 4B), suggesting that the observed ECM in
the xenografts is derived from WM266-4 cells.
Intriguingly, ECM detected in heterogeneous xenografts was
more abundant than inWM266-4 homogeneous xenografts (Fig-
ures 4C and S3A–S3C), a further indication of reciprocal commu-
nication between the two subpopulations. Additionally, cocultur-
ing WM266-4 cells with 501mel cells in a transwell system
resulted in increased ECM protein expression in both cell lines
(Figure S3D), suggesting the involvement of diffusible factors in690 Cell Reports 8, 688–695, August 7, 2014 ª2014 The Authorsthis communication. Moreover, ECM deposition was further
augmented in xenografts comprising WM2664-cells depleted
forMT1-MMPor treatedwithprotease inhibitors, andmatrix com-
ponents were more diffuse (Figures 4C and S3A–S3C). However,
protease inhibitiondidnot lead to furthercollagen I andfibronectin
induction inour in vitro coculture system (FigureS3D). This implies
that the increased amount and disorder observed because of
protease inhibition in vivo (Figures 4C and S3A–S3C) may be
due to modulating ECM turnover rather than expression.
Cooperative Invasion Depends on Fibronectin
In addition to the ECM around the WM266-4 tumor mass, we
also observed ECM around invading cells (Figure 4A). Close ex-
amination revealed fibers of fibronectin and collagen I radiating
away from the xenograft (Figure S3E), typical of the arrays of
collagen fibers detected around breast tumors that are associ-
ated with files of invading cells (Provenzano et al., 2006). In het-
erogeneous xenografts, we observed that both WM266-4 and
501mel cells appear to migrate in close connection to the tracks
of ECM (Figure 4C). Quantitation showed that during cooperative
invasion, cells were found predominantly on these collagen and
fibronectin tracks (Figure 4D).
To test whether ECM deposition was essential for cooperative
invasion, we generated WM266-4 cells expressing low levels of
fibronectin through RNA interference (WM266-4 shFN#1 and
shFN#2 cells). The reduction of fibronectin production was
confirmed in vitro with western blotting (Figure 5A). In vivo, the
Figure 3. A Diffusible Factor Emanating
from 501mel Cells Modulates WM266-4 Cell
Response to Protease Inhibitors
(A) Cartoon depicting experimental set-up, with
WM266-4 spheroids being cocultured either with
autologous cells or heterologous cells in porous
transwells.
(B) Representative images of WM266-4 spheroids
cocultured either with WM266-4 or 501mel cells in
the presence of a cocktail of protease inhibitors.presence ofWM266-4 shFN cells led to a significant loss of fibro-
nectin deposition around either homogeneous or heterogeneous
xenografts when compared to xenografts containing control
WM266-4 cells (Figures 5B and S4A), confirming that the fibro-
nectin associated with the xenograft was derived largely from
WM266-4 cells. When we analyzed collagen deposition, we
found that fibronectin knockdown did not affect the expression
of collagen I in WM266-4 or its deposition in vivo (Figures S4B
and S4C), suggesting that collagen deposition was independent
of fibronectin. WhenWM266-4 shFN cells were injected as a het-
erogeneous mixture with 501mel cells, the invasion of 501mel
cells was dramatically reduced when compared to heteroge-
neous xenografts containing WM266-4 control cells (Figures
5B and 5C), andmore so for shFN#1 than shFN#2 cells reflecting
the magnitude of fibronectin knockdown. This suggested that
cooperative invasion of 501mel cells requires the presence of
WM266-4 generated fibronectin tracks. In line with such a role
for fibronectin, invasive UACC62 cells also express significantly
more fibronectin than 888mel cells (Figure S1F). Interestingly, the
reduction in fibronectin expression appeared to not affect the
invasion of WM266-4 cells in homogeneous xenografts (Fig-
ure S4D). However, their invasion was impaired in heteroge-
neous tumors when fibronectin deposition was suppressed
(Figures 5B and 5C), further supporting a reciprocal communica-
tion between the individual melanoma cell subpopulations in a
heterogeneous setting.
MITFhigh and MITFlow Cells Are Present in the Invasive
Front of Tumors
One of the major determinants of melanoma heterogeneity is the
regulation of MITF expression by the tumor microenvironment
(Hoek et al., 2008). Further, a microenvironment-induced switch
to a MITFlow phenotype is thought to drive tumor invasion (Car-Cell Reports 8, 688–6reira et al., 2006). Although MITF expres-
sion correlates with the invasiveness of
individual cell populations (see Figure 1B
and Figure S1D), the cooperative invasion
observed in heterogeneous xenografts
(see Figures 1C and S1D) suggested that
both MITFhigh and MITFlow cells could
contribute to tumor invasion. Indeed,
immunofluorescence to detect MITF ex-
pression in heterogeneous xenografts re-
vealed that MITFhigh and MITFlow cells
invade together (Figure 5D), indicating
that MITF downregulation is not requiredfor cooperative invasion. To extend these findings into the clin-
ical setting, human melanoma biopsies were also examined for
MITF expression. Consistent with MITF heterogeneity being pre-
sent in invading cells, MITF staining revealed that MITFhigh and
MITFlow cells coexist in groups of melanoma cells invading the
dermis (Figure S5A), which is also apparent in other published
data (King et al., 1999) and in biopsy samples displayed in the
Human Protein Atlas http://www.proteinatlas.org (Uhlen et al.,
2010; Figure S5B).
DISCUSSION
Tumors usually display a high degree of genotypic and pheno-
typic heterogeneity, but the impact of heterogeneity on tumor
progression is not understood. Using a novel xenograft model,
we explored the possibility of phenotypically divergent mela-
noma cells cooperating during the first steps of tumor progres-
sion by analyzing their invasive behavior. We describe here
what we call cooperative invasion, during which heterogeneous
melanoma cell subpopulations interact reciprocally andmobilize
collectively.
Our data suggest that both proteolytic activity as well as ECM
deposition are necessary for cooperative invasion because
disruption of either completely abrogates invasion in heteroge-
neous xenografts. Moreover, we show that protease activity is
required to organize rather than simply degrade the ECM. It is
known that the ECMwithin a tumor is distinct from normal tissue,
due not only to alterations in composition, but also through
increased ECM stiffness (Levental et al., 2009). Alterations in ten-
sion alone can be sufficient to alter tumor cell invasion via integ-
rin activation (Friedland et al., 2009). Thus, WM266-4-produced
fibronectin could trigger changes in integrin signaling in 501mel
cells, or provide tracks serving as paths for invading 501mel95, August 7, 2014 ª2014 The Authors 691
Figure 4. ECM Proteins Correlate with Inva-
siveness
(A) Expression of ECM components collagen I and
fibronectin in engrafted zebrafish 4 dpi; arrows
indicate direction of invasion.
(B) Western blot showing collagen I and fibronectin
expression in WM266-4 and 501mel cells.
(C) Collagen I (upper) and fibronectin (lower) in
homogeneous compared to heterogeneous xeno-
grafts that are further treated with either DMSO or
GM6001.
(D) InvasiveWM266-4 and 501mel follow collagen I
(upper) and fibronectin (lower) tracks radiating out
from the tumor.
(E) Quantitation of ECM association. Cells were
scored as being in touch ‘‘on’’ with collagen I or
fibronectin strands or not ‘‘off.’’ Mean ± SEM;
unpaired Student’s t test (collagen) and Mann-
Whitney test (fibronectin); ****p < 0.0001; n R 18
from three independent experiments.
Scale bars represent 100 mm. See also Figure S3.cells. However, the full mechanism of this role of fibronectin is yet
to be resolved.
Another important finding from our study is that the mode of
invasion of WM266-4 cells switches from protease independent
in homogeneous xenografts to MT1-MMP dependent in hetero-
geneous xenografts and resembles what has been described as
collective invasion of chains of invading cells (Wolf et al., 2007).
We hypothesize that 501mel cells secrete factors that induce an
elongated morphology in WM266-4 cells thereby constraining
them to adopt a protease-driven leader role in invasion; however,
this soluble ‘‘switch factor’’ can be cleaved by proteases
secreted by WM266-4 cells, allowing them to use ‘‘rounded’’
invasion when the ‘‘switch factor’’ is sufficiently neutralized.
Potentially the same or possibly alternative secreted factors
emanating from 501mel cells also augment ECM density in het-
erogeneous xenografts, which would too promote a protease-
dependent invasion mode (Wolf et al., 2013). Together, our data
highlight that when cells cooperate, the underlying cell-cell com-
munications produce reciprocal effects on the individual subpop-
ulations (see Figure 5E for a model). Identifying the underlying692 Cell Reports 8, 688–695, August 7, 2014 ª2014 The Authorsmechanismswill be crucial if we are to fully
understand the impact of heterogeneity
on invasion. Moreover, the reciprocal
communication underlying cooperation
may itself be a therapeutic target.
Tumor progression is a complex
cascade of events requiring tumor cells
to detach from the primary tumor, invade
locally, intravasate, survive in circulation,
extravasate, and finally colonize distant
organs. How cancer cells acquire all
these capabilities has been the subject
of considerable speculation. Historically,
competition between genetically diver-
gent cancer cell variants leading to
expansion of the ‘‘fittest’’ clone was
thought to drive metastasis (Greavesand Maley, 2012). However, in multiple tumor types, secondary
tumors retain the heterogeneity of primary tumors, display
remarkably similar gene expression, and have very similar con-
stellations of mutations (Ramaswamy et al., 2003; Vakiani
et al., 2012; Vignot et al., 2013; Walter et al., 2012), challenging
the clonal expansion model.
An alternative theory proposes that cancer cells switch
behavior reversibly in response to transient changes in gene
expression, which are triggered by microenvironmental cues
(e.g., hypoxia or inflammation). As such, in carcinomas, revers-
ible transitions between epithelial andmesenchymal phenotypes
(EMT 4 MET) throughout tumor progression might explain
some of the similarity seen in primary and secondary tumors
(Scheel and Weinberg, 2012). In melanoma, phenotype switch-
ing is thought to follow altered MITF expression (Hoek and God-
ing, 2010). In both examples, a switch is proposed to occur to
generate different phenotypes with only one phenotype being
compatible with a particular stage of tumor progression. How-
ever, this is contradicted by our observation that the invasive
front in both our xenograft model and patient biopsies comprise
Figure 5. Fibronectin Is Essential for Coop-
erative Invasion; Invasive Primary Mela-
noma Cells Are Also Heterogeneous
(A) Western blot showing stable knockdown of
fibronectin in WM266-4 GFP shFN cells. #1 and #2
are clones expressing independent shRNA tar-
geting fibronectin. Control (con) cells express an
irrelevant shRNA.
(B) Fibronectin associated with heterogeneous
xenografts comprising either control WM266-4
cells (upper) or WM266-4 shFN#1 cells (lower).
(C) Quantitation of invasion of 501mel and
WM266-4 cells from heterogeneous xenografts
comprisingeither controlWM266-4cells,WM266-4
shFN#1, or WM266-4 shFN#2 cells. Mean ± SEM;
Mann-Whitney test; *p < 0.05, **p < 0.001, ***p <
0.001; nR 18 from three independent experiments.
(D) MITF immunofluorescence in frozen sections of
heterogeneous xenografts. Arrows indicate high
and low MITF fluorescence intensity in invading
cells.
(E) Model depicting the reciprocal interactions
underlying cooperative invasion.
See also Figures S4 and S5.heterogeneous cells. Moreover, melanoma cell clusters circu-
lating in patient blood were shown to express MITF heteroge-
neously (Khoja et al., 2014).
We believe that a process that maintains tumor heterogeneity
throughout progression based on cancer cell cooperation better
explains the preservation of heterogeneity in metastases. In sup-
port of this notion, other examples have emerged that demon-
strate cooperative behavior among cancer cells. For instance,
in Drosophila, separate clones of cells bearing RasV12 and
scribble mutations can interact to propagate Jnk signaling re-
sulting in neoplasia (Wu et al., 2010). In a mouse breast cancer
model driven by MMTV-Wnt1, tumors were identified containing
distinct basal Hrasmut Wnt1low and luminal Hraswt Wnt1high sub-Cell Reports 8, 688–6clones, both of which were required for
efficient tumor propagation (Cleary et al.,
2014). Furthermore, carcinoma cells that
had undergone EMT can cooperate with
cancer cells that still possess all epithelial
traits to induce lung metastasis (Tsuji
et al., 2008), and EMT and non-EMT cells
were also discovered coexisting in circu-
lating tumor cell clusters (Hou et al.,
2012; Yu et al., 2013). Symbiotic interac-
tions between individual cancer cell
subpopulations may well affect drug re-
sponses (as we have seen with protease
inhibitors), and, in the future, tumor het-
erogeneity should be addressed in pre-
clinical stages of drug development.
EXPERIMENTAL PROCEDURES
Cell Culture
Cells were maintained at 37C/5% CO2 in
Dulbecco’s modified Eagle’s medium (Sigma) sup-plemented with 10% fetal bovine serum (Sigma) and 0.5% penicillin-strepto-
mycin (Sigma). Prior to injection, UACC62 cells were stained with CellTrace
CFSE Cell Proliferation Kit (Invitrogen). WM266-4 shFN cells were generated
with the Block-iT Pol II miR RNAi expression vector kit (Invitrogen). MT1-
MMP knockdown in WM266-4 cells was achieved by transfecting 2nM siRNA
against MT1-MMP (Dharmacom) using INTERFERin (Polyplus Transfection)
transfection reagent.
Xenograft Assay
All animal studies described within were approved by The University of
Manchester Ethical Review Board and performed according to UK Home
Office regulations. Suspended cells were injected into the pericardial cavity
of 48 hr postfertilization zebrafish embryos. Engrafted embryos were main-
tained at 34C for 4 days. As needed, embryos were treated at 1 day postin-
jection (dpi) with DMSO (Sigma) or a cocktail of protease inhibitors or95, August 7, 2014 ª2014 The Authors 693
GM6001 alone (for 72 hr). At 4 dpi, embryos were fixed in 4% paraformalde-
hyde (PFA, Sigma) in PBS at 4C overnight.
Whole-Mount Immunofluorescence
Embryos were incubated with anti-collagen I (1:800 dilution, rabbit polyclonal,
1:4,000 dilution; Rockland Immunochemicals) and anti-fibronectin (1:1,000
dilution, mouse monoclonal Ab6328; Abcam) antibodies and then with sec-
ondary Alexa Fluor antibodies: anti-mouse 594, anti-mouse 633, anti-rabbit
594, and anti-rabbit 633 (1:150 dilution, Invitrogen).
Microscopy and Analysis
Tumors were imaged at 1 and 4 dpi using a Leica TCS SP5 AOBS upright
confocal (Leica Microsystems). Z stacks were processed using Volocity soft-
ware (Perkin Elmer). All experiments were performed a minimum of three
times. Relative invasion is defined as the average number of cells located
outside the pericardial cavity at 4 dpi normalized to the average number for
the control group. All statistical analysis was performed using GraphPad Prism
version 5 (GraphPad Software).
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